期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
多效组合蚕药与蚕种配套技术的研究
1
作者 羿红 兰其总 +2 位作者 林友照 付国平 肖胜刚 《福建热作科技》 1999年第3期1-4,共4页
用消毒剂845、蚕用氯霉素、灭蚕蝇3种蚕药,将3种或前种蚕药以张种正常剂量为单位,组成能有效防治生产中常见蚕病的多效组合蚕药,并与蚕种及消毒防病技术规程配套发放到农村,确保了蚕茧生产的无病、优质、高产。
关键词 多效组合 蚕药 蚕种 消毒 防病
下载PDF
“多效组合蚕药”与蚕种配套技术的试验示范总结
2
作者 羿红 付国平 刘捷 《福建热作科技》 1996年第3期18-20,共3页
“多效组合蚕药”与蚕种配套技术的试验示范总结羿红,付国平,刘捷(福建省蚕桑研究所)(邵武市蚕桑办354000)蚕病是影响蚕茧生产稳产、高产的重要因素之一。如何有效地防治蚕病,是实现蚕茧优质高产的技术关键。针对因药效单... “多效组合蚕药”与蚕种配套技术的试验示范总结羿红,付国平,刘捷(福建省蚕桑研究所)(邵武市蚕桑办354000)蚕病是影响蚕茧生产稳产、高产的重要因素之一。如何有效地防治蚕病,是实现蚕茧优质高产的技术关键。针对因药效单一,品种繁多造成在使用蚕药时盲目性... 展开更多
关键词 多效组合蚕药 蚕病 防治
下载PDF
Efficient synthesis of poly(oxymethylene) dimethyl ethers over PVP-stabilized heteropolyacids through self-assembly 被引量:4
3
作者 Xiaolong Fang Jin Chen +2 位作者 Linmin Ye Haiqiang Lin Youzhu Yuan 《Science China Chemistry》 SCIE EI CAS CSCD 2015年第1期131-138,共8页
A series of polyvinylpyrrolidone-stabilized heteropolyacids(PVP-HPAs)are generated by self-assembly of HPAs and PVP in methanol.The PVP-HPAs are then employed as catalysts for the synthesis of poly(oxymethylene)dimeth... A series of polyvinylpyrrolidone-stabilized heteropolyacids(PVP-HPAs)are generated by self-assembly of HPAs and PVP in methanol.The PVP-HPAs are then employed as catalysts for the synthesis of poly(oxymethylene)dimethyl ethers(DMMn,n1)by the methanolysis of trioxane.The results suggest that the acidity of PVP-HPAs is tunable by changing the ratio of PVP and HPAs,which is a key factor for the selectivity of the DMMn product.By optimizing the composition and reaction conditions,two types of PVP-HPA,PVP-phosphotungstic acid(PVP-HPW)in a PVP/HPW ratio of 1/4:1 and PVP-silicotungstic acid(PVP-HSi W)in a PVP/HSi W ratio of 1/4:3/4,respectively afford 52.4%and 50.3%yields of DMM2–5.The optimized catalysts are reusable for a minimum of 10 times without a significant drop in performance. 展开更多
关键词 poly(oxymethylene) dimethyl ethers METHANOL TRIOXANE HETEROPOLYACIDS POLYVINYLPYRROLIDONE
原文传递
Preparation and evaluation of doxorubicin-luminespib co-loaded multivesicular liposomes
4
作者 Yajie Liu Yu Wang +2 位作者 Jiajia Li Xiaoqing Xu Xinru Li 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第9期736-742,共7页
A combinational therapeutic system that simultaneously administrates various pathways is preferred for anti-cancer treatment.In the present study,we successfully constructed a co-delivery system,multivesicular liposom... A combinational therapeutic system that simultaneously administrates various pathways is preferred for anti-cancer treatment.In the present study,we successfully constructed a co-delivery system,multivesicular liposomes(MVLs)co-encapsulating doxorubicin(DOX)and luminespib(AUY922).A simple and accurate dual-wavelength spectrophotometric method was established for the determination of DOX and AUY922 in liposomal formulation.MVL-loading drugs were prepared by a multi-emulsion solvent evaporation method,which exhibited excellent physicochemical properties,such as particle size of 3–8μm and high entrapment efficiency above 95%for DOX and 73%for AUY922.The synergetic cytotoxic effect for these two drugs was evaluated in MDA-MB-231 cells.The in vitro antitumor studies demonstrated the superior anti-proliferation activity of DOX and AUY922 with a combination index of 0.43,indicating a great synergistic effect.The experimental data suggested that combinational use of DOX and AUY922 within liposomes could be an effective way to develop efficient treatments of cancers. 展开更多
关键词 DOXORUBICIN Luminespib Multivesicular liposomes Combination therapy Synergistic effect
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部